NCT03674567 2025-01-24Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with PembrolizumabRAPT Therapeutics, Inc.Phase 1/2 Completed323 enrolled
NCT05955105 2024-05-21A Study of ILB2109 and Toripalimab in Patients With Advanced Solid MalignanciesInnolake BiopharmPhase 1/2 Recruiting200 enrolled